In a major scientific breakthrough, newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Trees of Hope: Jen continues to be cancer free and connected with MOCA wdio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wdio.com Daily Mail and Mail on Sunday newspapers.
Trees of Hope: MOCA makes a difference for women in many ways wdio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wdio.com Daily Mail and Mail on Sunday newspapers.
<p>In a study led by investigators from <a href="https://www.massgeneralbrigham.org/" target=" blank">Mass General Brigham</a>, <a href="https://wyss.harvard.edu/" target=" blank">the Wyss Institute for Biologically Inspired Engineering at Harvard University</a> and <a href="https://www.dana-farber.org/" target=" blank">Dana-Farber Cancer Institute</a>, in collaboration with researchers from across the country and beyond the U.S., researchers developed a low-cost, ultrasensitive blood test to detect minute levels of a cancer biomarker that is highly specific to multiple common cancers. Each test can be performed with merely half a drop of blood (25 microliters). The tool showed promise for early cancer detection and disease monitoring, and could potentially be used in conjunction with other tools for detection, risk stratification and treatment. Results are published in <a href=&quo